Residents of St. Louis have an opportunity to participate in a landmark study that has the potential to change the face of cancer for future generations. Men and women between the ages of 30 and 65 who have never been diagnosed with cancer are needed to participate in the American Cancer Society’s Cancer Prevention Study-3 (CPS-3). CPS-3 will follow 300,000 people across the United States and Puerto Rico for more than 20 years to better identify cancer causing factors. The opportunity for local residents to enroll in CPS-3 is being made possible in partnership with UMB Bank, KPMG, Edward Jones, Centene, Siteman Cancer Center, Maritz Holdings, Inc., and Monsanto. For more information on eligibility and to schedule an appointment visit CancerStudyMO.org or call 888-604-5888. For more information about the American Cancer Society’s longitudinal study go to cancer.org/cps3.
Open Study Enrollments Dates and Locations: Enrollment times vary by location. To schedule a 30 minute appointment, visit CancerStudyMO.org.
Tuesday, April 23 & Wednesday, April 24
UMB Bank and KPMG
10 South Broadway, St. Louis, MO 63102
Thursday, April 25
Edward Jones Corporate Headquarters
12555 Manchester Rd, Des Peres, MO 63131
Tuesday, April 30
Centene Corporate Headquarters
7700 Forsyth Blvd, Clayton, MO 63105
Tuesday, April 30 & Wednesday, May 1
Siteman Cancer Center
4921 Park View, St. Louis, MO 63110
Wednesday, May 1
Maritz Holding, Inc.
1375 N. Highway Drive, Fenton, MO 63099
Thursday, May 2
Monsanto Headquarters
800 North Lindbergh, St. Louis, MO 63141
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.